Drug Profile
Research programme: G-protein-coupled receptor modulators - Lundbeck
Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Lundbeck A/S
- Class Small molecules
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Parkinson's disease
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Parkinson's-disease in Denmark
- 14 Oct 2013 Lundbeck secures grant from Michael J. Fox Foundation to finance development of G-protein-coupled receptor modulators for Parkinson's disease
- 14 Oct 2013 Early research in Parkinson's disease in Denmark (unspecified route)